Venter Jan A, Berry Colin W, Hannan Noelle C, Raju Dasi, Kiss Huba J, Belovari Mirna, Hannan Stephen J, Cooper David R, Schallhorn Julie M
Optical Express, Glasgow, UK.
Department of Ophthalmology, University of California, San Francisco, CA, USA.
Clin Ophthalmol. 2025 Apr 4;19:1203-1214. doi: 10.2147/OPTH.S511743. eCollection 2025.
To compare the performance of an enhanced and conventional monofocal IOL in eyes with early and intermediate age-related macular degeneration (AMD).
This retrospective study compared one-month postoperative outcomes of patients bilaterally implanted with TECNIS Eyhance IOL (ICB00 group) or TECNIS Monofocal IOL (ZCB00 group). All patients underwent cataract surgery with pre-existing early or intermediate dry AMD. Outcome measures were monocular and binocular uncorrected distance (UDVA), intermediate (UIVA) and near (UNVA) visual acuity, monocular corrected distance visual acuity (CDVA), and refractive outcomes. Monocular visual acuities and refractive predictability were calculated for the dominant eye of each patient.
The ICB00 group comprised 143 eyes of 143 patients, while 164 eyes of 164 patients were included in the ZCB00 group. Preoperative characteristics were comparable between the two groups. There was no significant difference in postoperative refractive predictability, with 87.4% and 89.6% of eyes within 0.50 D of emmetropia in the ICB00 and ZCB00 groups, respectively (p=0.54). No difference was found in postoperative UDVA or CDVA between the groups. Both monocular and binocular UIVA were significantly better in the ICB00 group (monocular UIVA: 0.32±0.19 vs 0.42±0.22 logMAR, p<0.001; binocular UIVA: 0.25±0.18 vs 0.36±0.17 logMAR, p<0.001). Postoperative UNVA was also better with the ICB00 IOL (monocular UNVA: 0.58±0.16 vs 0.69±0.20 logMAR, p<0.001; binocular UNVA: 0.50±0.16 vs 0.63±0.17 logMAR, p<0.001).
ICB00 IOL enhanced intermediate and near vision in patients with AMD while achieving the same level of corrected and uncorrected distance visual acuity.
比较增强型和传统单焦点人工晶状体在患有早期和中期年龄相关性黄斑变性(AMD)的眼中的性能。
这项回顾性研究比较了双侧植入TECNIS Eyhance人工晶状体(ICB00组)或TECNIS单焦点人工晶状体(ZCB00组)的患者术后1个月的结果。所有患者在术前已患有早期或中期干性AMD的情况下接受了白内障手术。结果指标包括单眼和双眼未矫正远视力(UDVA)、中视力(UIVA)和近视力(UNVA)、单眼矫正远视力(CDVA)以及屈光结果。计算了每位患者优势眼的单眼视力和屈光可预测性。
ICB00组包括143例患者的143只眼,而ZCB00组包括164例患者的164只眼。两组术前特征具有可比性。术后屈光可预测性无显著差异,ICB00组和ZCB00组分别有87.4%和89.6%的眼在正视眼0.50 D范围内(p = 0.54)。两组术后UDVA或CDVA无差异。ICB00组的单眼中视力和双眼中视力均显著更好(单眼中视力:0.32±0.19 vs 0.42±0.22 logMAR,p<0.001;双眼中视力:0.25±0.18 vs 0.36±0.17 logMAR,p<0.001)。ICB00人工晶状体的术后近视力也更好(单眼近视力:0.58±0.16 vs 0.69±0.20 logMAR,p<0.001;双眼近视力:0.50±0.16 vs 0.63±0.17 logMAR,p<0.001)。
ICB00人工晶状体在AMD患者中增强了中视力和近视力,同时达到了相同水平的矫正和未矫正远视力。